|2.||Aggressive Fibromatosis (Desmoid)
|5.||Abdominal Aortic Aneurysm
|1.||Vaglio, Augusto: 15 articles (11/2015 - 01/2005)|
|2.||Buzio, Carlo: 12 articles (11/2015 - 01/2005)|
|3.||Salvarani, Carlo: 12 articles (11/2015 - 04/2005)|
|4.||Pipitone, Nicolò: 8 articles (11/2015 - 04/2005)|
|5.||Versari, Annibale: 6 articles (11/2015 - 04/2005)|
|6.||Palmisano, Alessandra: 6 articles (11/2015 - 06/2011)|
|7.||Boiardi, Luigi: 5 articles (09/2013 - 04/2005)|
|8.||Maritati, Federica: 4 articles (11/2015 - 06/2011)|
|9.||Corradi, Domenico: 4 articles (11/2015 - 07/2011)|
|10.||van Bommel, Eric F H: 4 articles (03/2014 - 01/2006)|
07/15/1997 - "Tamoxifen seems to be effective in the treatment of idiopathic retroperitoneal fibrosis by inducing a regression of the fibrotic masses. "
07/01/2013 - "Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis."
03/01/2000 - "To evaluate the efficacy of tamoxifen in the treatment of idiopathic retroperitoneal fibrosis in one patient and to review the results reported in the literature. "
01/01/2014 - "To evaluate the therapeutic effect of tamoxifen monotherapy in patients with retroperitoneal fibrosis (RPF). "
01/01/2014 - "Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis."
12/01/2013 - "After exclusion of a secondary genesis, in which case therapy of the underlying illness would be necessary, idiopathic chronic periaortitis can be treated with steroids. "
07/01/2006 - "To review a 10-year experience of medical treatment for idiopathic retroperitoneal fibrosis (RPF), a rare condition of unknown causes, which may obstruct the ureter and for which treatment includes ureterolysis and relief of obstruction, and medical treatment with steroids with or without immunosuppressive medication. "
08/01/2002 - "We treated 12 patients with idiopathic retroperitoneal fibrosis with a regimen of steroids during a 10-year period. "
07/01/1997 - "Successful treatment of idiopathic retroperitoneal fibrosis with steroids."
12/01/1993 - "A patient with idiopathic retroperitoneal fibrosis with a positive Ga-67 scan was successfully treated with steroids. "
|3.||mycophenolate mofetil (Cellcept)FDA LinkGeneric
04/01/2007 - "Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis."
10/01/2008 - "To assess the therapeutic benefit of mycophenolate mofetil (MMF) in retroperitoneal fibrosis (RF). "
10/01/2008 - "Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis."
05/01/2008 - "Mycophenolate mofetil in the treatment of retroperitoneal fibrosis."
04/01/2008 - "Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil."
|4.||Prednisone (Sone)FDA LinkGeneric
07/23/2011 - "Therefore, prednisone should be considered as first-line treatment for patients with newly diagnosed idiopathic retroperitoneal fibrosis. "
05/01/2007 - "Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone."
06/01/1983 - "In view of the similarities between this condition and retroperitoneal fibrosis, 5 patients were treated with Prednisone 5 mg twice daily for up to 18 months and a CAT scan technique developed to monitor the degree of thickening quantitatively. "
07/23/2011 - "Prednisone is more effective in prevention of relapses than is tamoxifen in patients with idiopathic retroperitoneal fibrosis. "
01/04/2011 - "Combined prednisone and mycophenolate mofetil therapy is a potentially effective treatment for retroperitoneal fibrosis that warrants evaluation in randomized trials. "
|5.||Adrenal Cortex Hormones (Corticosteroids)IBA
07/01/2006 - "The conventional approach for management of retroperitoneal fibrosis (RF), an inflammatory process of retroperitoneal fibro-adipose tissue, leading to the compression and obstruction of the ureters and other adjacent organs is ureterolysis with omental wrapping, and an effective alternative to surgery is immunosupressive medication such as oral corticosteroids. "
03/01/2003 - "There is no clear evidence of the beneficial effect of corticosteroids treatment on the course of retroperitoneal fibrosis. "
01/01/1995 - "He had been taking corticosteroids for retroperitoneal fibrosis for 15 days. "
09/01/1994 - "The conventional treatment of patients with ureteric obstruction due to retroperitoneal fibrosis (RF) is surgery in combination with long-term corticosteroids. "
01/01/1992 - "Review of 7 patients with idiopathic retroperitoneal fibrosis (IRF), treated with a combination of corticosteroids (6-methyl-prednisolone) and endourological procedures. "
|6.||Pergolide (Permax)FDA Link
01/01/2009 - "Retroperitoneal fibrosis improved with pergolide cessation and corticosteroid treatment. "
01/01/2010 - "Retroperitoneal fibrosis secondary to pergolide therapy."
07/01/2000 - "Retroperitoneal fibrosis is a rare complication of pergolide therapy. "
07/01/2000 - "Pergolide-induced retroperitoneal fibrosis."
01/01/2009 - "Retroperitoneal fibrosis is best described as a chronic inflammatory process which may be idiopathic, but can rarely be brought about by medications, such as pergolide, used for treating Parkinson's disease. "
|7.||Prednisolone (Predate)FDA LinkGeneric
10/01/2001 - "Prednisolone appears to be useful in the treatment of intrathoracic extension of retroperitoneal fibrosis."
06/01/2014 - "Because it was determined that the patient could have IgG4-RD, he was administered prednisolone, following which a decrease in the size of the pituitary stalk and retroperitoneal fibrosis was observed. "
03/01/2003 - "We diagnosed both cases as retroperitoneal fibrosis and administered prednisolone for 10 months. "
05/01/2001 - "Under a diagnosis of retroperitoneal fibrosis, bilateral nephrostomies were temporarily placed and prednisolone administration was initiated at a dose of 20 mg/day. "
07/01/1998 - "He was diagnosed as idiopathic retroperitoneal fibrosis and was treated with prednisolone. "
09/01/2012 - "Glucocorticoids are the mainstay of treatment of idiopathic retroperitoneal fibrosis (IRF). "
07/23/2011 - "Glucocorticoids are the mainstay of treatment of idiopathic retroperitoneal fibrosis, but they often have substantial toxic effects. "
09/01/2013 - "Chronic periaortitis (CP) usually responds to glucocorticoids, but some patients have glucocorticoid-refractory disease or contraindications to glucocorticoid therapy. "
01/01/2011 - "IgG4 related disease is a chronic immunopathological disorder, proposed as a new diagnostic entity, and characterized as follows: 1. background is in multiorgan lymphoplasmocellular infiltration associated with presence of large number of polyclonal IgG4+ plasma cells, and fibrosclerosis; 2. structural damage of the affected organs is frequently associated with pseudotumorous enlargement and/or other morphological changes; for example aortitis with aneurysmatic dilatation, sclerosing pancreatitis, retroperitoneal fibrosis ect.; 3. serum concentration of IgG4 is usually significantly elevated; 4. responsivity to glucocorticoids is a hallmark of the disease: in rare cases of glucocorticoid-resistance a response to rituximab was observed. "
12/01/2009 - "Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4."
02/01/2015 - "Immunoglobulin G4 (IgG4)-related disease has been suggested to be involved in cardiovascular disorders such as chronic periaortitis. "
01/01/2015 - "Immunoglobulin G4-related paratesticular fibrous pseudotumor and retroperitoneal fibrosis: a case report."
01/01/2015 - "Contrast-enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in immunoglobulin G4-related retroperitoneal fibrosis."
06/01/2014 - "We report a case of possible immunoglobulin G4-related disease(IgG4-RD)that resulted in complications such as retroperitoneal fibrosis and infundibulohypophysitis. "
|10.||Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/01/2013 - "18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis."
01/01/2012 - "Several studies have evaluated the role of fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in diagnosing and assessing disease activity in patients with retroperitoneal fibrosis (RF). "
03/01/2013 - "To systematically review the literature data on the role of Fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in patients with retroperitoneal fibrosis (RF), PubMed/MEDLINE, Embase and Scopus databases were searched for articles that evaluated the usefulness of FDG-PET and PET/CT in patients with RF from inception to March 31, 2012. "
03/01/2013 - "Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review."
05/01/2012 - "18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?"
03/18/1982 - "The morbidity related to external radiotherapy (megavoltage technique, delivering 45 grays in 5 weeks) was low: only one patient developed retroperitoneal fibrosis. "
01/01/1992 - "To my knowledge this is the first reported case of retroperitoneal fibrosis occurring after radiotherapy for testicular cancer."
01/01/1992 - "Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma."
06/01/1989 - "Retroperitoneal fibrosis in radiotherapy-treated ankylosing spondylitis."
01/01/2007 - "We report the case of a patient with a non-Hodgkin lymphoma, who after a standard chemotherapy protocol, developed retroperitoneal fibrosis (RPF) in the absence of radiotherapy or other known causes. "
|2.||Drug Therapy (Chemotherapy)
02/01/2007 - "Retroperitoneal fibrosis after chemotherapy: part 2."
01/01/2007 - "Retroperitoneal fibrosis after chemotherapy."
01/01/2000 - "One year after termination of chemotherapy retroperitoneal fibrosis was no longer detectable. "
11/01/2001 - "[A case of idiopathic retroperitoneal fibrosis causing acute renal failure and markedly responsive to drug therapy]."
12/03/1993 - "Other causes (tumour, drug therapy, inflammation) having been largely excluded, idiopathic retroperitoneal fibrosis was diagnosed. "
11/01/2015 - "To discover the relationship between computed tomography (CT) parameters of retroperitoneal soft tissue of untreated retroperitoneal fibrosis patients and the variation of renal function after treatment. "
08/01/2010 - "At follow-up 1 year after treatment with acitretin ceased, the patient remained free of cutaneous lesions and his overall condition, including the retroperitoneal fibrosis, had improved. "
11/01/1990 - "Retroperitoneal fibrosis disappeared after treatment with corticosteroids. "
04/22/1989 - "[Retroperitoneal fibrosis after treatment with bromocriptine]."
04/15/1989 - "[Retroperitoneal fibrosis after treatment by bromocriptine]."
|4.||Kampo Medicine (Kampo)
05/01/2014 - "Immunoglobulin G4-Related Retroperitoneal Fibrosis Treated with Hochuekkito, a Kampo Medicine, following Steroid Treatment."
05/01/2014 - "We report a case of immunoglobulin G4 (IgG4)-related retroperitoneal fibrosis (RF) with complete remission and no relapses after therapy with steroids and Hochuekkito, a Kampo (i.e. "
07/01/1996 - "Urodynamic studies using a stent indwelling model for retroperitoneal fibrosis]."
03/01/2014 - "Both intraureteral stent and percutaneous nephrostomy placement are a safe way to relieve urinary obstruction in idiopathic retroperitoneal fibrosis patients, and they have comparable complication rates. "
01/01/2014 - "To review our experience with and the effectiveness of the ureteral Memokath 051 metallic stent for the minimally invasive management of retroperitoneal fibrosis (RPF). "
01/01/2008 - "Nineteen months earlier, he had been diagnosed with idiopathic retroperitoneal fibrosis and treated with bilateral ureteric stents. "
11/01/2007 - "Of the stents, 68% were placed for malignancy, 23% for retroperitoneal fibrosis, and 9% for benign masses. "